In the last years, some studies on the usefulness of 18F-fluorodeoxyglucose PET/computed tomography (18F-FDG PET/CT) for the evaluation of male breast cancer (MBC) have been produced. The aim of this review is to analyze the usefulness of 18F-FDG PET/CT and its diagnostic performances for the assessment of MBC
PMCID: PMC4299771To evaluate (18)F-labeled-fluorodeoxyglucose ((18)F-FDG-) and (18)F-labeled-sodium ...
To evaluate the clinical value of 16α-[18F]fluoroestradiol (18F-FES) PET/CT in assisting the individ...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...
The rationale was to develop recommendations on the use of 18F-FDG PET in breast, colorectal, esopha...
PurposeWe aimed to investigate the relationship between histopathological and immunohistochemical fe...
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the eval...
THE POTENTIAL VALUE of positron emission tomography with 18F-fluorodeoxyglucose (FDG PET) for diagno...
This short review is dedicated to the current status of the assessment of a new PET radiopharmaceuti...
18F-FDG PET in combination with conventional imaging modalities could help avoid unnecessary biopsy ...
The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile su...
Our objective was to retrospectively evaluate 18F-FDGPET/CT in the initial staging of inflammatory b...
Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer worldwide, with...
The clinical utility of 18F-FDGPET in evaluating salivary glandma-lignancies has not been well defin...
Purpose: To reassess the usefulness of 18F-FDG PET in the differential diagnosis of benign and malig...
(18)F-FDG PET/CT is used in a variety of cancers, but because of variable rates of glucose metabolis...
PMCID: PMC4299771To evaluate (18)F-labeled-fluorodeoxyglucose ((18)F-FDG-) and (18)F-labeled-sodium ...
To evaluate the clinical value of 16α-[18F]fluoroestradiol (18F-FES) PET/CT in assisting the individ...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...
The rationale was to develop recommendations on the use of 18F-FDG PET in breast, colorectal, esopha...
PurposeWe aimed to investigate the relationship between histopathological and immunohistochemical fe...
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the eval...
THE POTENTIAL VALUE of positron emission tomography with 18F-fluorodeoxyglucose (FDG PET) for diagno...
This short review is dedicated to the current status of the assessment of a new PET radiopharmaceuti...
18F-FDG PET in combination with conventional imaging modalities could help avoid unnecessary biopsy ...
The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile su...
Our objective was to retrospectively evaluate 18F-FDGPET/CT in the initial staging of inflammatory b...
Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer worldwide, with...
The clinical utility of 18F-FDGPET in evaluating salivary glandma-lignancies has not been well defin...
Purpose: To reassess the usefulness of 18F-FDG PET in the differential diagnosis of benign and malig...
(18)F-FDG PET/CT is used in a variety of cancers, but because of variable rates of glucose metabolis...
PMCID: PMC4299771To evaluate (18)F-labeled-fluorodeoxyglucose ((18)F-FDG-) and (18)F-labeled-sodium ...
To evaluate the clinical value of 16α-[18F]fluoroestradiol (18F-FES) PET/CT in assisting the individ...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...